Writing Interventions for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if specific writing exercises can help breast cancer patients adhere to their medication more consistently and reduce stress. Participants will engage in either reflective journaling or value affirmation, writing short essays once a month for six months. The trial targets individuals diagnosed with breast cancer who are starting or planning to start aromatase inhibitors. Participants must speak English and own a smartphone.
As an unphased trial, this study offers a unique opportunity to explore personal growth and stress reduction techniques while contributing to valuable research.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, it seems that participants are expected to continue taking their prescribed aromatase inhibitors during the study.
What prior data suggests that these writing interventions are safe for breast cancer patients?
Research shows that both reflective journaling and value affirmation are safe and easy activities. Reflective journaling has been used in therapy for breast cancer survivors. Participants in these studies generally found journaling positive and helpful, with no harmful effects reported. It can improve mood and reduce stress by allowing expression of thoughts and feelings.
Value affirmation is also safe. Studies suggest it can increase optimism and positive feelings among cancer survivors. By focusing on personal values, individuals often feel less stressed and experience better emotional health. No negative side effects have been reported from value affirmation exercises.
Overall, both activities are non-invasive, meaning they don't involve any physical procedures or medications. This makes them low-risk options for supporting health and well-being during cancer treatment.12345Why are researchers excited about this trial?
Researchers are excited about these writing interventions for breast cancer because they offer a unique, non-pharmacological approach to supporting patients' mental well-being. Reflective Journaling encourages participants to engage with perspectives outside their immediate values, potentially broadening their worldview and providing a sense of connection with others. Value Affirmation, on the other hand, focuses on reinforcing personal values, which can help boost self-esteem and resilience during treatment. Unlike traditional treatments like chemotherapy or hormone therapy, these interventions are simple and accessible, requiring only ten minutes of writing per session, and can be easily integrated into daily life.
What evidence suggests that these writing interventions could be effective for improving medication adherence and reducing stress in breast cancer patients?
This trial will compare two writing interventions for breast cancer patients: reflective journaling and value affirmation. Research has shown that reflective journaling can improve quality of life and reduce stress, tiredness, and anxiety. Participants in this trial may engage in reflective journaling, which involves writing about values that are not important to them and discussing why these values could be important to others. In contrast, value affirmation has been linked to fewer physical symptoms and less distress in breast cancer survivors. Participants may also engage in value affirmation, focusing on personal values to increase optimism and improve mental well-being. Both methods offer promising ways to help breast cancer patients manage their symptoms and stress.12467
Who Is on the Research Team?
J. David Creswell, Ph.D.
Principal Investigator
Carnegie Mellon University
Janine Dutcher, Ph.D
Principal Investigator
Carnegie Mellon University
Are You a Good Fit for This Trial?
This trial is for postmenopausal breast cancer patients who plan to take aromatase inhibitors, can read and write in English, have a smartphone for app use, and are either currently prescribed or will be prescribed the medication within four weeks. It's not for those with claustrophobia, metal implants, electronic medical devices, current pregnancy, weight over 300 pounds or a metal-containing IUD (specifically for fMRI part of the study).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants complete monthly writing tasks for six months, either value affirmation or reflective journaling
Post-Intervention Assessment
Assessment of physical symptoms and perceived stress one month after intervention
Follow-up
Participants are monitored for changes in stress and physical symptoms six months after post-intervention assessment
What Are the Treatments Tested in This Trial?
Interventions
- Reflective Journaling
- Value Affirmation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Carnegie Mellon University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator